Related Experiment Video

Updated: May 19, 2026

Isolated Pancreatic Islet Treatment and Apoptosis Measurement
09:36

Isolated Pancreatic Islet Treatment and Apoptosis Measurement

Published on: May 2, 2025

Apoptosis of human islet cells by cytokines

Sunshin Kim1, Kyoung-Ah Kim, Kyoungho Suk

  • 1New Experimental Therapeutics Branch, Division of Convergence Technology, National Cancer Center, Goyang 410-769, Korea.

Immune Network
|August 24, 2012
PubMed

Insights

Interferon-gamma (IFNγ) and Tumor Necrosis Factor-alpha (TNFα) synergistically induce apoptosis in human islet cells. This IFNγ/TNFα synergism may contribute to beta-cell death in type 1 diabetes.

Area of Science:

  • Immunology
  • Endocrinology
  • Cell Biology

Background:

  • Autoimmune diabetes involves beta-cell death, with effector molecules like FasL, perforin, TNFα, IL-1, and NO implicated but not definitively identified.
  • Previous research suggested a synergistic role for Interferon-gamma (IFNγ) and Tumor Necrosis Factor-alpha (TNFα) in murine autoimmune diabetes, inducing apoptosis in beta-cells.

Purpose of the Study:

  • To investigate the role of IFNγ/TNFα synergism in human pancreatic islet cell apoptosis.
  • To determine if IFNγ/TNFα-induced apoptosis in human islet cells involves similar molecular mechanisms as observed in murine models.

Main Methods:

  • Treatment of human pancreatic islet cells with IFNγ and TNFα, individually and in combination.
  • Analysis of STAT1 activation and IRF-1 induction following IFNγ treatment.
  • Assessment of apoptosis in treated human islet cells.

Main Results:

  • IFNγ/TNFα synergism was found to induce apoptosis in human pancreatic islet cells.
  • IFNγ treatment activated STAT1 and induced IRF-1 in human islet cells, mirroring findings in murine models.
  • Neither IFNγ nor TNFα alone induced significant apoptosis, highlighting the requirement for their synergistic action.

Conclusions:

  • IFNγ/TNFα synergism is a potential mechanism for human islet cell death in type 1 diabetes.
  • The findings suggest a conserved pathway of beta-cell destruction in both murine and human autoimmune diabetes involving IFNγ and TNFα.
Keywords:
ApoptosisAutoimmunityCytokinesDiabetesInflammatory mediators

More Related Videos

Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes12:12

Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes

Published on: June 16, 2011

Staining Protocols for Human Pancreatic Islets07:48

Staining Protocols for Human Pancreatic Islets

Published on: May 23, 2012

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...